VersaPro™ Anhydrous Base
VersaPro™ Anhydrous Base is MEDISCA’s newest addition to the tried and tested VersaPro family. This new base has been specially developed and manufactured to achieve a water activity below 0.6 to allow for extended 180 day default BUDs, as per current USP <795> guidelines. VersaPro Anhydrous Base is scientifically formulated to contain several ingredients to promote drug delivery of both lipophilic and hydrophilic APIs providing compounders the versatility they need. It also contains a combination of silicone and natural oils to provide the ideal patient sensory experience, with a soft, moisturized feel. Combining the much loved versatility of the VersaPro family, with its low water activity below 0.6, VersaPro Anhydrous Base provides even more compounding opportunities for your pharmacy.
VersaPro™ Anhydrous Base is MEDISCA’s newest addition to the tried and tested VersaPro family. This new base has been specially developed and manufactured to achieve a water activity below 0.6 to allow for extended 180 day default BUDs, as per current USP <795> guidelines.
Combining the much loved versatility of the VersaPro family, with its low water activity below 0.6, VersaPro Anhydrous Base provides even more compounding opportunities for your pharmacy.
Backed by Science.
VersaPro Anhydrous Base contains a variety of penetration enhancers that work together to form a synergistic effect to promote the absorption of compounded preparations.
- Formulated with penetration enhancers to increase drug delivery through the skin1
- Contains solubilizers to promote dissolution of both lipophilic and hydrophilic actives
- Naturally-derived oils act as an emollient to maintain skin hydration and optimize transdermal absorption
- Film-forming ingredients improve retention time on the skin
- Water activity tested <0.6
- Passes HRIPT - hypoallergenic and dermatologist tested
1. N. Dragicevic, H.I. Maibach (eds.), Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Modifi cation of the Stratum Corneum, DOI 10.1007/978-3-662-47039-8_12 Yousef J., Adibkia K., Hamishekar H. Transcutol® (Diethylene Glycol Monoethyl Ether): A Potential Penetration Enhancer. 2015
